CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

Summary: The apoptosis inducing receptor CD95/Fas has multiple tumorigenic activities. In different genetically engineered mouse models tumor-expressed CD95 was shown to be critical for cell growth. Using a combination of immune-deficient and immune-competent mouse models, we now establish that loss...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Abdul S. Qadir, Jean Philippe Guégan, Christophe Ginestier, Assia Chaibi, Alban Bessede, Emmanuelle Charafe-Jauffret, Manon Macario, Vincent Lavoué, Thibault de la Motte Rouge, Calvin Law, Jacob Vilker, Hongbin Wang, Emily Stroup, Matthew J. Schipma, Bryan Bridgeman, Andrea E. Murmann, Zhe Ji, Patrick Legembre, Marcus E. Peter
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Immunology
Cell biology
Cancer
Science
Q
Accès en ligne:https://doaj.org/article/01c1b9341da244a5b4a9946be1c614bf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/01c1b9341da244a5b4a9946be1c614bf

Documents similaires